RecruitingNCT06040073

Natural History of Coronary Atherosclerosis

Natural History of Coronary Atherosclerosis Based on Multimodal Imaging and Physiological Fusion Techniques (NASCENT)


Sponsor

China National Center for Cardiovascular Diseases

Enrollment

125 participants

Start Date

Jul 7, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The present study sought to explore the predictive value of radial wall strain (RWS, derived solely from angiograms) for coronary artery lesion progression compared with lesion vulnerability assessed by optical coherence tomography (OCT). The lesion progression at 1 year was defined as an increase of ≥20% in diameter stenosis based on quantitative coronary angiography (QCA) evaluation.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age ≥18 years
  • Acute myocardial infarction ≤ 45 days
  • Planned coronary angiography examination or potential interventional treatment
  • The presence of at least 1 non-flow-restricting lesion (visually estimated diameter stenosis: 30%-80%; QFR \> 0.80) in any non-infarct related artery with RVD ≥2.5 mm by visual assessment

Exclusion Criteria8

  • Cardiogenic shock
  • Pregnant or woman of child-bearing potential
  • Life expectancy less than 1 year for non-cardiac causes
  • Unable to tolerate contrast agents or anticoagulant/antiplatelet therapy
  • Prior CABG or planned CABG
  • Poor angiographic image quality precluding vessel contour detection or with suboptimal contrast opacification, branch ostium cannot be shown clearly, severe overlap in the stenosed segment or severe tortuosity of any interrogated vessel deemed not amenable to QFR or RWS measurement
  • An interrogated lesion require surgical bypass grafting
  • Unable to judge culprit lesion or infarct-related artery according to current evidence

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Lei Song

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06040073


Related Trials